Zimmer Biomet Holdings Inc (ZBH) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Zimmer Biomet Holdings Inc   (NYSE: ZBH)


Zimmer Biomet Holdings Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Zimmer Biomet Holdings Inc 's ROA in the second quarter of 2026?
Zimmer Biomet Holdings Inc achieved a return on average assets (ROA) of 3.36 % in its second quarter of 2026, which is below Zimmer Biomet Holdings Inc 's average return on assets, which stands at 3.6%.

Despite the company's net income deteriorating, Zimmer Biomet Holdings Inc was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector 178 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1519, from total ROA ranking in the first quarter of 2026 at 1855.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 17.63 % 2.42 % 8.08 % 8.14 % 6.25 %
Y / Y Net Income Change 30.12 % 30.5 % -42.52 % -7.26 % -36.9 %
Net Income (TTM) in million 807 761 705 807 825
Return On Assets (TTM) 3.36 % 3.3 % 3.08 % 3.59 % 3.75 %
ZBH's Total Ranking # 1519 # 1855 # 1467 # 1412 # 1327
Total Assets (TTM) in million 26,897 22,722 23,092 23,488 22,865
Seq. Total Assets Change 18.38 % -1.6 % -1.69 % 2.72 % 3.07 %
Seq. Net Income Change -16.24 % 72.68 % -40.31 % 50.72 % -15.99 %



Return On Assets Company Ranking
Within: No.
Industry # 53
Sector # 179
Overall # 1472

Return On Assets Statistics
High Average Low
9.29 %
3.6 %
-1.48 %
(Sep 30 2010)   (Dec 31 2018)





Financial Statements
Zimmer Biomet Holdings Inc 's Assets $ 26,897 million ZBH's Balance sheet
Zimmer Biomet Holdings Inc 's Income $ 200 million Quarterly ZBH's Income Statement
ZBH's Income by Division See ZBH's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 8.08 % -0.61 % 2.05 % -10.19 % -3.94 %
Total Assets in million 23,092 21,365 21,497 21,066 23,456
Y / Y Net Income Change -22.1 % -11.69 % 341.09 % -42.2 % -
Net Income in million 705 905 1,025 232 402
Annual Return On Assets 3.05 % 4.24 % 4.77 % 1.1 % 1.71 %




Comment on ZBH's ROA in the fiscal year ending 2025
In the fiscal year 2025 Zimmer Biomet Holdings Inc 's ROA decreased compared to previous year to 3.05 %, due to deterioration of net income -22.1 % to $705.20 million, from $905.30 million a year ago, as ZBH's assets were $23,091.70 million.


More Return On Assets Ratios
ZBH's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ZBH's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ZBH's Competitors
Subscribers only: Roa for Zimmer Biomet Holdings Inc 's Suppliers
Subscribers only: Return On Assets for ZBH's Customers

You may also want to know
ZBH's Roi ZBH's Inventory Turnover Ratio ZBH's Growth Rates ZBH's Dividend Comparisons
ZBH's Profitability Ratios ZBH's Asset Turnover Ratio ZBH's Dividend Growth
ZBH's Roe ZBH's Valuation Ratios ZBH's Financial Strength Ratios ZBH's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Tactile Systems Technology Inc   9.17 %
Bioventus Inc   9.08 %
Infusystem Holdings Inc  8.63 %
Penumbra Inc  8.63 %
Utah Medical Products Inc  8.50 %
Boston Scientific Corporation  8.34 %
3m Company  8.27 %
Jazz Pharmaceuticals Plc  8.19 %
Pediatrix Medical Group Inc   8.09 %
Veracyte Inc   8.04 %
Stryker Corp  7.89 %
Lifevantage Corp  7.87 %
Embecta Corp   7.82 %
Beone Medicines Ltd   7.82 %
Viemed Healthcare Inc   7.49 %
Edwards Lifesciences Corporation  7.41 %
Ani Pharmaceuticals Inc  7.40 %
Addus Homecare Corp  7.32 %
Livanova Plc  7.31 %
Pacific Health Care Organization Inc  7.17 %
Nature s Sunshine Products inc   7.14 %
Bio techne Corp  7.12 %
Concentra Group Holdings Parent Inc   7.09 %
Phibro Animal Health Corporation  7.01 %
Ensign Group Inc  6.88 %
Royalty Pharma Plc  6.87 %
Davita Inc   6.77 %
Quest Diagnostics Inc  6.74 %
Align Technology inc   6.56 %
Corcept Therapeutics Inc  6.45 %


Date modified: 2026-09-11T09:47:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.